1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Other Specified Pulmonary Tuberculosis: new trials by email Literature Review of Other Specified Pulmonary Tuberculosis trials Research Report on Other Specified Pulmonary Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) BTZ-043, Rifafour e-275®, Probe Drug Cocktail - Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis | Phase 1 / Phase 2 | Completed | Michael Hoelscher | 78 | 2019-11-15 | 2026-08-31 |
Gram-Positive Bacterial Infections (1) · Tuberculosis (1) · Tuberculosis, Pulmonary (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (1) · Ethambutol (1) · Isoniazid (1) · Pyrazinamide (1) · Rifampin (1) · dolutegravir (1)
South Africa (1)
Andreas Diacon, Prof (1) · Michael Hoelscher, Prof (1)